11 funding opportunities are listed in this category
BD Biosciences Research Grant Program
Grant applications can be submitted by US scientists focused on stem cell research, multicolor flow cytometry, cell signaling, cancer research, immune function, infectious diseases, or neuroscience research. The BD Biosciences Research Grant Program aims to reward and enable important research by providing vital funding for scientists pursuing innovative experiments to advance the scientific understanding of disease. Through its grant program, BD Biosciences works to support innovation in research and development, helping to define the next generation of scientific breakthroughs. How to Apply The application process is simple. Just write an abstract, complete the online application, review and accept the program terms and conditions, and submit. Important Dates Application start date: May 8, 2010 Application deadline: September 3, 2010 Winners to be announced December 11, 2010
Application Guidelines We welcome your most innovative ideas and encourage you to submit abstracts within evolving research areas that include: Stem cell research Multicolor flow cytometry Cell signaling Cancer research Immune function Infectious diseases Neuroscience research
Applications will be judged by a panel of distinguished scientists from academic and other research institutions. Awards will be based on the application's creativity, content, and innovation, including how you propose to use BD Biosciences reagents to further your research study's goals. Before receiving awards, winners must sign a contract and other forms confirming eligibility and agreeing to abide by the rules of the grant. BD 1 Becton Drive Franklin Lakes, New Jersey USA, 07417 201.847.6800
BD Biosciences 2350 Qume Drive San Jose, California USA, 95131 877.232.8995
The Eric Marder Scholarship Program of The Immune Deficiency Foundation
The Immune Deficiency Foundation is honored to award scholarships to undergraduate students living with primary immunodeficiency diseases who plan on completing their secondary education. The Eric Marder Scholarship Program is open to patients with a primary immunodeficiency as classified by the World Health Organization and is intended for undergraduate students attending or entering college or a technical training school. The Eric Marder Scholarship Program of the Immune Deficiency Foundation is made possible by donations to a scholarship fund to honor Eric Marder, a vibrant young man whose life was cut short at the age of 28 by complications of Common Variable Immune Deficiency. This scholarship program not only honors Eric's memory, it also helps students who also have primary immunodeficiency diseases attend college and pursue their dreams. Online applications will be accepted beginning January 2, 2010. The scholarship deadline is March 31, 2010 and awards will be announced in June 2010.
IDF Eric Marder Scholarship Program 40 W. Chesapeake Avenue Suite 308 Towson, MD 21204
E-mail: idf@primaryimmune.org Web site: www.primaryimmune.org
Irvington Institute Fellowship Program of the Cancer Research Institute The Irvington Institute Fellowship Program of the Cancer Research Institute (formerly called the Cancer Research Institute Postdoctoral Fellowship Program), established in 1971, is our longest-standing continuous program to support and train young immunologists at top universities and research centers. Over the past 38 years, 968 young scientists have received postdoctoral fellowship awards from CRI, including two who later won the Nobel Prize. In 2007, following the merger of the Cancer Research Institute and the Irvington Institute for Immunological Research, the program was renamed after the Irvington Institute to reflect the considerable value of Irvington's assets, all of which have been directed into the postdoctoral fellowship program. As a result, CRI increased the number and level of fellowship awards it makes each year, effective in fiscal year 2008. The Institute has funded 998 fellows since 1971, two of whom have gone on to win the Nobel Prize, and many others who now fill top scientific positions at universities and medical centers around the world.
Within the framework of this program, the Institute is able to provide the brightest young scientists the means to embark on a career in immunology research. Our fellows have different research interests and conduct their work in laboratories around the world, but they all support the Institute's driving mission to conquer cancer through immunology by increasing our understanding of the human immune system. Mentored by some of the world’s leading immunologists, these young researchers bring fresh insight and enthusiasm to their work, receiving postgraduate training while carrying out the seminal research that can lead to the next wave of major discoveries in the field. Fellowship candidates are rigorously evaluated by a panel of 23 members of our Scientific Advisory Council. The selection is highly competitive and is based on the qualifications and experience of both the applicant and the proposed sponsor, as well as the nature and feasibility of the intended line of inquiry and the overall training environment. Deadlines for application are April 1 and October 1 annually. Fellowship appointments are for three years, with graded stipends at $45,000 for the first year, $47,000 for the second, and $49,000 for the third. A yearly allowance of $1,500 is provided to the host institution to help meet expenses for research supplies, travel to scientific meetings, and health insurance incurred on behalf of the fellow. Fellows are encouraged to attend CRI’s annual symposium, where they have an opportunity to present posters of their research while interacting with world-leaders in both basic and clinical cancer immunology. CRI fellows have made numerous contributions to the peer-reviewed scientific publications that advance our understanding of the immune system and its relationship to cancer.
Phone 1-800-99CANCER or 1-800-992-2623 (212) 688-7515 9 a.m. and 5 p.m. Eastern Time weekdays Fax (212) 832-9376 Mail Cancer Research Institute National Headquarters One Exchange Plaza 55 Broadway, Suite 1802 New York, NY 10006
Questions about our research funding programs should be directed to grants@cancerresearch.org.
2011 Thomas E. Starzl Prize in Surgery and Immunology
The Thomas E. Starzl Transplantation Institute is accepting nominations for the 2011 Thomas E. Starzl Prize in Surgery and Immunology, awarded annually to a national or international leader in the field of organ transplantation. The prize consists of a crystal award, an honorarium of $15,000, and travel expenses to the University of Pittsburgh School of Medicine in the spring of 2011 to formally receive the award and to present the Thomas E. Starzl Prize in Surgery and Immunology lecture. Over a two-day period, the winner will also participate in related activities and meet informally with faculty, postdoctoral fellows and students. Nomination deadline: May 3, 2010
The Thomas E. Starzl Prize in Surgery and Immunology, previously known as the Annual Thomas E. Starzl Lectureship, was established in 1996 by the Department of Surgery and subsequently endowed by Fujisawa Healthcare, Inc. (currently Astellas Pharma, Inc.) to honor the clinical and scientific contributions of Dr. Thomas E. Starzl. Outstanding national and international leaders who have made significant contributions to the fields of organ transplantation and immunology are invited to the University of Pittsburgh to present their work and receive the prize. Dr. Starzl joined the University of Pittsburgh in 1981 to direct the Pittsburgh Transplantation Institute, which in 1996 was renamed the Thomas E. Starzl Transplantation Institute. He now holds the position of Professor of Surgery and Distinguished Service Professor at the University of Pittsburgh. Dr. Starzl was the first to transplant kidneys in humans with consistent success, perform liver transplantation, and successfully transplant human intestines. He introduced four commonly used immunosuppressive drugs (prednisone, ALG, cyclophosphamide, and tacrolimus) for clinical transplantation. The discovery in 1992 by Dr. Starzl and colleagues of donor-derived leukocytes in the tissues of long-term functioning organ transplant recipients unmasked a fundamental principle of transplantation tolerance. Dr. Starzl’s seminal contributions to the field of organ transplantation and immunology have been recognized around the globe. His most recent distinctions include the 2004 National Medal of Science, the nation’s highest scientific honor, the 2009 Department of Veterans Affairs Diamond Award for Lifetime Achievement in the Field of Transplantation Medicine, and the 2009 Institute of Medicine Gustav O. Lienhard Award. Nomination Procedure Please submit the following information electronically to starzlprize@upmc.edu: 1. a completed nomination form (available on http://stiresearch.health.pitt.edu), 2. a letter of nomination with a detailed description of the research accomplishments that qualify the nominee for this award, and 3. a copy of the nominee’s current curriculum vitae. The deadline for receipt of all nomination materials is May 3, 2010. Questions concerning the Thomas E. Starzl Prize in Surgery and Immunology or the nomination process may be referred to 412-383-8884 or starzlprize@upmc.edu.
Eli Lilly and Company Research Award
ASM's oldest and most prestigious prize, it rewards fundamental research of unusual merit in microbiology or immunology by an individual on the threshold of his or her career. Eligibility:The nominee's work is not judged by comparison with the research of more experienced scientists, and special consideration is given to originality and independence of thought. The nominee must not have reached his or her 45th birthday by April 30 of the year the award is given. The nominee must be working in the United States or Canada and be actively engaged in the line of research for which the award is to be made.Award:A cash prize of $5,000, a commemorative piece, and travel to the ASM General Meeting where the laureate delivers the Eli Lilly Award Lecture.Deadline: October 1.Nominations:Nominations will be reconsidered annually so long as eligibility criteria are met and an updated curriculum vitae is submitted. Self-nominations and more than one nomination per nominee will not be accepted. Only one nominating form and two supporting forms are accepted per nomination. The two supporters must be persons other than the nominator who are familiar with the nominee's qualifications and accomplishments. Only one of the three individuals involved in the nomination may be employed at the nominee's institution. The nominator and supporters must not share employers. Nominations must consist of the following: * Curriculum vitae, including a list of publications, emailed to awards@asmusa.org * Photocopy or scanned file of driver's license, passport, or birth certificate to verify date of birth, emailed to awards@asmusa.org * Nominating form * Supporting formASM awards are granted at the discretion of award selection committees and may not be awarded every year.
American Society for Microbiology1752 N Street, N.W.Washington, D.C. 20036-2904(202) 737-3600
Abbott Laboratories Award in Clinical and Diagnostic ImmunologyHonors a distinguished scientist in clinical or diagnostic immunology for outstanding contributions to those fields.Eligibility:The nominee must demonstrate significant contributions to the understanding of the functioning of the host immune system in human disease, clinical approaches to diseases involving the immune system or development or clinical application of immunodiagnostic procedures.Award:A cash prize of $2,000, a commemorative piece, and travel to the ASM General Meeting where the laureate is the ASM Division V Lecturer. Deadline: October 1.Nominations:Nominations will be considered without updating for three years. Self-nominations and more than one nomination per nominee will not be accepted. Only one nominating form and two supporting forms are accepted per nomination. The two supporters must be persons other than the nominator who are familiar with the nominee's qualifications and accomplishments. Only one of the three individuals involved in the nomination may be employed at the nominee's institution. The nominator and supporters must not share employers. Nominations must consist of the following: * Curriculum vitae, including a list of publications, emailed to awards@asmusa.org * Nominating form * Supporting formASM awards are granted at the discretion of award selection committees and may not be awarded every year.
Society for Hematology and Stem Cells Travel Grants to ISEH 2010 Meeting
Date: 15 - 18 September, 2010Location: Melbourne Convention & Exhibition Centre, Melbourne Australia (www.mcec.com.au/)
Through the generous support of the State government of Victoria we are able to offer up to 200 travel grants for PhD students and post-doctoral delegates as follows:Delegates traveling from Europe AUD$2000Delegates traveling from the USA AUD$1500Delegates traveling from Asia AUD$1200Delegates traveling from New Zealand or within Australia AUD$300Applications need to be submitted with your abstract and will be assessed based on the abstract rankings. Travel award applicants must also include a letter from their Mentor/Supervisor with their abstract submission requesting travel support and identifying need. *You must be an ISEH member to apply for a travel grant.
Key Dates: * Registration /Abstract Submission Open; March 1, 2010 * Abstract Submissions Close: May 1, 2010 * Travel Grant Requests Close: May 1, 2010 * Early Bird Registration Closes: June 1, 2010
The Society for Hematology and Stem Cells (ISEH) was established in 1950 by a group of scientists who sought to create a forum for the presentation and discussion of pre-clinical data in experimental hematology. ISEH continues to be dedicated to the promotion of the scientific knowledge and clinical application of basic hematologic and immunologic disorders through research, publications, and scientific programs. Incorporated in 1972 in the USA, the Society has over 800 active members from 40 countries around the world. Its annual scientific meeting attracts more than 500 participants over 4 days and, together with its official monthly journal Experimental Hematology, provides essential delivery of quality education, training programs, discussion forums, as well as promotes basic research.KnowledgeOffering comprehensive programs and publications in training and education, ISEH membership provides the tools for expansive understanding and cutting-edge methodologies from around the globe.InnovationProviding the latest scientific information, ISEH members are at the forefront of advances in experimental hematology including: * Progenitor cells, hematopoiesis, growth factors and cytokines * Immunology * Mechanisms of hematologic malignancies (leukemias, lymphomas, myelomas) * Oncology * Oncogenes * Stem Cell niches * Cancer stem cells * Gene profiling (microarray chips) and protein chips * Stem cell biology and transplantation (bone marrow, peripheral blood, cord blood) * Cellular therapy * Gene therapy * Hematopoietic microenvironment
For more information on how to apply for these grants contact ISEH@marqueemarketing.com.au
ISEH401 N. Michigan Ave, Ste 2400Chicago, IL 60611 USAPhone: (+1/202) 367-1183Fax: (+1/202) 367-2183E-mail: info@iseh.org
12next